Lazard Asset Management LLC Astrazeneca PLC Transaction History
Lazard Asset Management LLC
- $61.8 Billion
- Q4 2024
A detailed history of Lazard Asset Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lazard Asset Management LLC holds 918,666 shares of AZN stock, worth $62.1 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
918,666
Previous 1,160,869
20.86%
Holding current value
$62.1 Million
Previous $90.5 Million
33.46%
% of portfolio
0.1%
Previous 0.13%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,380Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.08 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.77 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.54 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.62 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.32 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $209B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...